Investor Presentaiton

Strong traction in B2C business (Non-Covid) Annual Trend B2C Business Revenue (Non-Covid) +49% +12% -11% +18% FY18 FY19 FY20 FY21 FY22 METROPOLIS The Pathology Specialist Our B2C business continue to witness robust growth on account of our customer first approach, digital & marketing initiatives Including Hitech Diagnostics from 22nd Oct, 2021 8

View entire presentation